Cart
sales@molnova.com
Aristololactam AII
CAS No. 53948-07-5
Aristololactam AII( ——— )
Catalog No. M38286 CAS No. 53948-07-5
Aristolactam A II is a Aristolactam. Aristolactam a small group of compounds mainly found in the Aristolochiaceae.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 949 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAristololactam AII
-
NoteResearch use only, not for human use.
-
Brief DescriptionAristolactam A II is a Aristolactam. Aristolactam a small group of compounds mainly found in the Aristolochiaceae.
-
DescriptionAristolactam AII has cytotoxic activity, it also shows platelet aggregation inhibitory activity.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorPAFR
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number53948-07-5
-
Formula Weight265.26
-
Molecular FormulaC16H11NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 11 mg/mL (41.47 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kumar V, et al. Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activitiesJ. Natural product reports, 2003, 20(6): 565-583.
molnova catalog
related products
-
3-Demethoxypiplartin...
Demethoxypiplartine is an amide alkaloids which can be isolated from Piper flaviflorum and Piper sarmentosum. Demethoxypiplartine has antifungal activity against Cryptococcus neoformans with the IC50 of 18.1 μg/mL.
-
N-p-coumaroyl-N'-caf...
N-p-Coumaroyl-N'-caffeoylputrescine is a natural product of Exochorda, Rosaceae. N-p-Coumaroyl-N'-caffeoylputrescine can be used as a reference standard.
-
1-Phenylbiguanide HC...
Compound PDK0269, as 5-HT3 receptor agonists(3–100 μM, pEC50 5.05±0.06), acutely increased XII (hypoglossal) burst frequency and regularity, and decreased bursts/episode .
